Article
Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer.
Clinical and translational gastroenterology - 1 Feb 2024
Rosner Guy, Scapa Erez, Ziv Tomer, Gluck Nathan, Ben-Yehoyada Merav
Abstract excerpt
INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate. PDAC surveillance is recommended in high-risk individuals (HRIs) with strong PDAC family history or a pathogenic germline variant (PGV) in a PDAC susceptibility gene. We aimed to explore a potential correlation between genetic status, extent of family history, pancreatic findings, and surveillance implications in heterogeneous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
